{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2022"],"condition":["Colorectal Cancer","Colorectal Neoplasms","Cancer"],"disease":["Colorectal Cancer","Colorectal Neoplasms","Cancer"],"study_type":["Observational"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2404245"],"location":["United States"],"study_start_month":["6"],"keyword":["Observational","Precision medicine","CRC","Genomic Profiling","Biomarkers","Oncology","NGS"],"repository":["ECRIN MDR"],"study_status":["Recruiting"],"additional_accession":[]},"is_claimable":false,"name":"Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays","description":"The study is an observational multicenter evaluation of participants with colorectal cancer (CRC) who will receive longitudinal plasma ctDNA biomarker profiling in addition to their standard-of-care therapy and disease surveillance.","dates":{"creation":"2022-06-15"},"accession":"2404245","cross_references":{"ClinicalTrials___gov":["NCT05234177"]}}